SERODIAGNOSIS OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS (ANTI-SARS-CoV-2) ANTIBODY IN BLOOD DONORS IN SURABAYA, INDONESIA
Abstract
Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2). So far, the incidence of direct blood-borne transmission is not widely known. This is because the viremia of SARS-CoV-2 virus infection is very small, between 2-3 days after infection. Immunoglobulin M (IgM) is an antibody that is formed in the early days of a person being infected with the virus, which is around the third day and can persist in the blood for up to 3-4 months after infection. The purpose of this study was to perform serodiagnosis of SARS-CoV-2 antibodies in blood donors in Surabaya. The type of research used is an experimental laboratory with an exploratory research design. The research sample consisted of 100 donor blood samples from UTD PMI Surabaya. Rapid diagnostic test examination at the Immunology Laboratory Department of Technology, Medical Laboratory, Poltekkes, Ministry of Health, and the Immunoserology Laboratory of BBLK Surabaya for antibody titer examination using the ELISA method in May 2022. Results of antibody analysis against SARS-CoV- 2 in blood donors in Surabaya by 58% (Cut Off Index = 0.1569), so further research is needed on factors that can affect the formation of antibodies.
Keywords
References
Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–62.
Banava S, Gansky SA, Reddy MS. Coronavirus Disease Update on Epidemiology, Virology, and Prevention. Compend Contin Educ Dent. 2021;42(6):280–9.
CDC. CDC Strategy for Global Response to COVID-19. 19. 2020. p. 1–5. Available from: www.cdc.gov
Mahallawi WH, Al-Zalabani AH. The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia. Saudi J Biol Sci. 2021;28(3):1697–701.
Younas A, Waheed S, Khawaja S, Imam M. (2020)Transfusion and Apheresis Science Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in. 2020;(January).
Nugroho HSW, Sillehu S, Suparji. Title of dissertation. University name; 2018.
Bag Soytas R, Cengiz M, Islamoglu MS, Borku Uysal B, Yavuzer S, Yavuzer H. Antibody responses to COVID-19 vaccines in older adults. J Med Virol. 2022;94(4).
Chang L, Hou W, Zhao L, Zhang Y, Wang Y, Wu L, et al. The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Nat Commun. 2021;12(1):1–10.
Ma H, Zeng W, He H, Zhao D, Yang Y, Jiang D, et al. COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by a quantitative and sensitive immunoassay. medRxiv. 2020;2020.04.17.20064907.
Alsuliman T et al. Antibody Expression and Production. 2011;
Banga Ndzouboukou JL, Zhang Y di, Lei Q, Lin X song, Yao Z jie, Fu H, et al. Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine. Curr Med Sci. 2021;41(6):1081–6.
Mitani A, Hamada K, Yoshikawa N, Morita Y. The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information . 2020;(January).
Alsuliman T, Sulaiman R, Ismail S, Srour M, Alrstom A. (2020) The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information . 2020;(January).
Yanti B, Ismida FD, Sarah KES. Perbedaan uji diagnostik antigen, antibodi, RT-PCR dan tes cepat molekuler pada Coronavirus Disease 2019. J Kedokt Syiah Kuala. 2020;20(3):172–7.
Crossroads Between Innate and Adaptive Immunity V. 2015.
Sars-cov- V, Kesehatan T. Konsistensi Respon Imun Humoral ( IgG ) SARS-CoV-2 Pasca. 2022;45(2):118–25.
Nisnawati, Niken, Yusuf RN. Perbedaan jumlah limfosit pada tenaga kesehatan yang sudah menerima vaksin dosis lengkap dengan yang tidak menerima vaksin COVID - 19 di RSUD Aceh Singkil. J Kesehat Saintika Meditory. 2021;2(4657):94–108.
Haft JW, Atluri P, Ailawadi G, Engelman DT, Grant MC, Hassan A, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020;8(5):518–26.
Cheng ZJ, Xue M, Zheng P, Lyu J, Zhan Z, Hu H, et al. Factors affecting the antibody immunogenicity of vaccines against sars-cov-2: A focused review. Vaccines. 2021;9(8):1–11.
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol [Internet]. 2020;16(3):177–89. Available from: http://dx.doi.org/10.1038/s41574-019-0310-7
Choi WS, Cheong HJ. COVID-19 vaccination for people with comorbidities. Infect Chemother. 2021;53(1):155–8.
Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, et al. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021;2021(9).
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 evy diah woelansari
"HEALTH NOTIONS" ISSN: 2580-4936 (online version only), published by Humanistic Network for Science and Technology
Cemara street 25, 001/002, Dare, Ds./Kec. Sukorejo, Ponorogo, East Java, Indonesia, 63453